CRONOS GROUP INC. (CRON) Gross Margin
- Gross margin · 12 months: Value 45.86%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 45.86% | Gross profit / revenue. Period ending 2026-06-30. $82.13M ÷ $179.09M × 100 ≈ 45.86% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 82.13M USD | Gross Profit |
| Revenue | 179.09M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $82.13M | $179.09M | (m) | 45.86% |
| 2026-03-31 | $68.18M | $159.53M | (m) | 42.74% |
| 2025-12-31 | $62.76M | $146.59M | (m) | 42.81% |
| 2025-09-30 | $57.38M | $132.36M | (m) | 43.35% |
| 2025-06-30 | $42.66M | $130.28M | (m) | 32.74% |
| 2025-03-31 | $34.45M | $124.59M | (m) | 27.65% |
| 2024-12-31 | $25.20M | $117.61M | (m) | 21.42% |
| 2024-09-30 | $16.30M | $111.23M | (m) | 14.66% |
| 2024-06-30 | $16.66M | $101.78M | (m) | 16.37% |
| 2024-03-31 | $13.46M | $93.03M | (m) | 14.47% |
| 2023-12-31 | $11.91M | $87.24M | (m) | 13.65% |
| 2023-09-30 | $7.79M | $90.51M | (m) | 8.61% |
| 2023-06-30 | $6.96M | $86.11M | (m) | 8.09% |
| 2023-03-31 | $7.42M | $87.02M | (m) | 8.53% |
| 2022-12-31 | $11.97M | $91.90M | (m) | 13.02% |
| 2022-09-30 | $14.15M | $94.81M | (m) | 14.92% |
| 2022-06-30 | $12.26M | $94.30M | (m) | 13.00% |
| 2022-03-31 | $-7.64M | $86.86M | (m) | -8.80% |
| 2021-12-31 | $-17.53M | $74.44M | (m) | -23.56% |
| 2021-09-30 | $-34.38M | $65.69M | (m) | -52.33% |
| 2021-06-30 | $-35.18M | $56.64M | (m) | -62.12% |
| 2021-03-31 | $-22.32M | $50.90M | (m) | -43.85% |
| 2020-12-31 | $-25.83M | $46.72M | (m) | -55.29% |
| 2020-09-30 | $-31.31M | $36.98M | (m) | -84.67% |
| 2020-06-30 | $-32.94M | $31.41M | (m) | -104.88% |
| 2020-03-31 | $-25.89M | $29.18M | (m) | -88.75% |
| 2019-12-31 | $-17.86M | $23.75M | (m) | -75.22% |
| 2019-09-30 | $4.39M | $20.73M | (m) | 21.18% |
| 2019-06-30 | $9.11M | $17.82M | (m) | 51.14% |
| 2019-03-31 | $6.68M | $12.80M | (m) | 52.19% |
| 2018-12-31 | $6.21M | $12.12M | (m) | 51.26% |
| 2018-09-30 | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) |
| 2017-12-31 | $1.57M | $3.15M | (m) | 50.02% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |